{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/63b80a52c8b42a00112a648d/6a744c20c3e1347e8b54f8be?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"Portfolio Spotlight: HexemBio","thumbnail_width":200,"thumbnail_height":200,"thumbnail_url":"https://open-images.acast.com/shows/63b80a52c8b42a00112a648d/1786006535709-a726d513-c2ae-471e-ad0b-b49451ccf96f.jpeg?height=200","description":"<p>In this Portfolio Spotlight episode of the Generation Space Podcast, Leah Martin is joined by Gabriel Levesque Tremblay, PhD, CEO and Co-Founder of HexemBio, and Seraphim Space Investor Jeffery Jiang to explore how regenerative medicine, AI and space-enabled research are converging to transform the future of healthcare. They discuss HexemBio's pioneering Synthetic Human Yolk Sac technology, its potential to rejuvenate aging blood stem cells and improve bone marrow transplantation, why Seraphim invested in the company, and the enormous opportunity at the intersection of biotechnology, artificial intelligence and space-enabled innovation.</p>","author_name":"Seraphim"}